Study of ARO-APOC3 in Adults With Dyslipidemia
Clinical trial NCT05413135 · COMPLETED
Trial details
- NCT number
- NCT05413135
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-07
- Primary completion
- 2025-09-22
- Enrollment
- 418
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.